News
Important Only
BREAKINGVIEWS-Sanofi finds M&A fix for its multiple itches
By Neil Unmack LONDON, June 2 (Reuters Breakingviews) - Sanofi SASY.PA is one European giant that’s still focused on the United States. The $123 billion French drugmaker will pay up to $9.5 billion for Blueprint Medicines BPMC.O, a U.S. group whose key product fights a rare blood disorder which ...Reuters
Mon, Jun 2
These Unstoppable Ultra-High-Yielding Dividend Stocks Have Increased Their Payments for at Least the Past 49 Straight Quarters
The best dividend stocks strive to increase their payments once a year. Over 150 have managed to do that for the past decade, which is impressive considering all that has transpired in the past 10 years. While many companies aim to give their investors an annual raise, some have a higher standard. T...The Motley Fool
Mon, Jun 2
Here's Why I Plan to Apply for Social Security at 1 of the Least Popular Claiming Ages
If you've ever looked into when you should claim Social Security, you've probably come across a lot of conflicting information. Nearly a quarter of all seniors sign up at 62 -- the earliest possible claiming age -- but others say that's a bad idea, because doing so shrinks your checks by up to 30% f...The Motley Fool
Mon, Jun 2
US STOCKS-Wall Street futures slip after Trump's steel tariff threat
Futures down: Dow 0.2%, S&P 500 0.31%, Nasdaq 0.44%Boeing rises on brokerage upgradeBlueprint Medicines gains on Sanofi's buyout offerBy Kanchana Chakravarty and Sukriti Gupta June 2 (Reuters) - U.S. stock index futures dipped on Monday following President Donald Trump's plans to doub...Reuters
Mon, Jun 2
Red Rock Resorts rises after Mizuho upgrades to 'outperform', hikes PT
** Shares of casino company Red Rock Resorts RRR.O rise 1.2% to $49 in premarket ** Mizuho upgrades stock to "outperform" from "neutral"** Raises price target to $59 from $50; new PT at a premium of 22.7% to stock's last close ** Says it believes RRR could be a beneficiary of...Reuters
Mon, Jun 2
U.S. STOCKS ON THE MOVE-Moderna, Blueprint Medicines, Boeing
The Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8U.S. stock index futures dipped on Monday after President Donald Trump announced plans to double tariffs on imported steel and aluminum, amplifying concerns about trade- and tariff-related v...Reuters
Mon, Jun 2
The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip
Even though broader equities have been highly volatile this year, it's still a good idea to invest in stocks for a straightforward reason. Holding shares of top companies for five years and beyond will usually allow anyone to earn superior returns. That's not a secret, but it's easy to forget when d...The Motley Fool
Mon, Jun 2
BioNTech climbs on cancer drug deal with Bristol Myers
** U.S.-listed shares of German vaccine maker BioNTech 22UAy.DE, BNTX.O rise 13.7% to $108.90 premarket** BNTX and Bristol Myers Squibb BMY.N announced global partnership to jointly develop and commercialize an experimental cancer drug, BNT327 ** BMY will pay BioNTech $1.5 billion upfront, up to $2 ...Reuters
Mon, Jun 2
Street View: EOG Resources' Encino deal on track to boost acreage position
** U.S. energy producer EOG Resources EOG.N said on Friday it will acquire Encino Acquisition Partners for $5.6 billion, including debt, to strengthen its Utica Shale position** Median PT of 31 brokerages covering stock is $139 - data compiled by LSEGANALYSTS REACT POSITIVELY TO EOG'S ENCINO DEA...Reuters
Mon, Jun 2
LIVE MARKETS-Europe's 'big 5' luxury brands may lose market share again in 2025-MS
STOXX 600 down 0.2%Trade policy uncertainty weighsPolish stocks lead way lowerWall St futures inch lowerWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.comEUROPE'S 'BIG 5' LU...Reuters
Mon, Jun 2
Boeing's Stock Is Crushing the Market in 2025. Can It Continue?
Boeing (NYSE: BA) stock is up 13.6% this year compared to a minimal gain for the S&P 500, primarily due to management's improved performance under relatively new CEO Kelly Ortberg, who was appointed last August and continues to steer the company in a positive direction. The key question is whether t...The Motley Fool
Mon, Jun 2
Tesla's European sales rout continues but new Model Y boosts Norway deliveries
Sales slump continues across much of Europe Norway offers bright spot with rollout of revamped Model YTesla slump comes as EV sales rise in Europe Shares drop in pre-market trade By Nick Carey LONDON, June 2 (Reuters) - Tesla's TSLA.O car sales fell sharply in several European markets includi...Reuters
Mon, Jun 2
How Long Do Bear Markets Last? Here's What History Tells Investors.
When you read about various people getting rich by investing in the stock market, it's perhaps natural to imagine that they had an easy time of it. Invest in stocks, wait a while, and get rich. It kind of does happen like that, but it's important to understand that the stock market doesn't go up in ...The Motley Fool
Mon, Jun 2
Prediction: Lockheed Martin Stock Could Explode as Donald Trump Touts F-55 Fighter Jet and a Bigger F-22
The Lockheed Martin (NYSE: LMT) F-22 Raptor stealth fighter is arguably the most expensive fighter jet ever built, costing an estimated $400 billion per unit. That's part of the reason it's no longer being built, by the way. (The F-22 program was canceled more than a decade ago, although the plane r...The Motley Fool
Mon, Jun 2
Vera Therapeutics jumps after kidney disease drug succeeds in late-stage trial
** Shares of drug developer Vera Therapeutics VERA.O rise 66.3% to $31.32 premarket** VERA says its kidney disease drug, atacicept, met main goal in a late-stage study to treat IgA nephropathy** IgA nephropathy causes a protein called immunoglobulin A to build up in the kidney ** Company says th...Reuters
Mon, Jun 2
Is Tesla Stock a Buy Now?
Tesla (NASDAQ: TSLA) shares are extremely volatile, but they have remarkably rewarded investors. Just in the past five years, they have climbed 530% (as of May 30). This is despite the pandemic, supply chain issues, inflationary pressures, and general economic uncertainty that have concerned investo...The Motley Fool
Mon, Jun 2
3 No-Brainer Healthcare Stocks to Buy in June
A new month has arrived. Investors now have a fresh opportunity to buy great stocks. Three Motley Fool contributors believe they've found no-brainer healthcare stocks to buy in June. Here's why they like Amgen (NASDAQ: AMGN), Vertex Pharmaceuticals (NASDAQ: VRTX), and Summit Therapeutics (NASDAQ: SM...The Motley Fool
Mon, Jun 2
Citigroup lowers PT on timber companies as lumber prices come under pressure
** Citigroup reduces price target on timber companies to reflect a more conservative outlook on lumber and log prices** Says lumber prices has drifted lower since the beginning of April with dealers working down inventories built in anticipation of Canadian tariffs that did not ultimately materializ...Reuters
Mon, Jun 2
HEDGE FLOW-Hedge funds buy stocks at quickest pace since Nov 2024, Goldman Sachs says
By Nell Mackenzie LONDON, June 2 (Reuters) - Hedge funds bought global equities last week at the quickest pace since November 2024, Goldman Sachs said in a note, just as stock markets ended the month with their most positive May performance in decades. The S&P 500 .SPX advanced just over 6% i...Reuters
Mon, Jun 2
Could Viking Therapeutics Become the Next Eli Lilly?
The obesity treatment market is booming, with groundbreaking drugs like Eli Lilly's (NYSE: LLY) Zepbound delivering transformative patient results and powering its stock to a spectacular 400% return in the past five years.Amid this estimated $100 billion opportunity, much smaller upstart Viking Ther...The Motley Fool
Mon, Jun 2
